Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

LOUISVILLE PATIENT CENTERED MEDICAL HOME, PSC

NPI: 1265604763 · LOUISVILLE, KY 40207 · Primary Care Clinic/Center · NPI assigned 03/25/2008

$732K
Total Medicaid Paid
78,064
Total Claims
69,239
Beneficiaries
86
Codes Billed
2018-01
First Month
2022-04
Last Month

Provider Details

Authorized OfficialCHARASIKA, JAMES (PRESIDENT/CEO)
NPI Enumeration Date03/25/2008

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 42,374 $293K
2019 28,150 $214K
2020 2,679 $83K
2021 4,174 $122K
2022 687 $20K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 5,975 5,014 $208K
99215 Prolong outpt/office vis 2,095 1,940 $172K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 2,686 2,446 $147K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 569 532 $47K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 534 494 $37K
99205 Prolong outpt/office vis 292 259 $34K
99407 372 353 $11K
90674 606 547 $9K
G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination 339 311 $9K
90460 Immunization administration through 18 years of age via any route, first or only component 426 294 $7K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 463 432 $7K
82947 1,377 1,118 $5K
36415 Collection of venous blood by venipuncture 1,968 1,808 $5K
99401 204 187 $4K
90651 25 25 $3K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 70 61 $3K
81003 1,776 1,638 $3K
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 5,346 4,475 $2K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 129 120 $2K
G8417 Bmi is documented above normal parameters and a follow-up plan is documented 4,090 3,437 $2K
92081 46 45 $2K
Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory 340 312 $1K
99442 60 55 $1K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 12 12 $988.90
G0447 Face-to-face behavioral counseling for obesity, 15 minutes 251 232 $744.80
36416 1,425 1,171 $716.87
90686 45 41 $486.41
90633 25 25 $474.97
G8420 Bmi is documented within normal parameters and no follow-up plan is required 1,258 1,072 $425.21
81025 62 57 $406.10
G8483 Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) 2,242 1,970 $405.05
3074F 4,646 4,014 $327.34
1111F 612 548 $311.21
3078F 4,003 3,518 $268.56
3725F 1,775 1,635 $267.85
G8510 Screening for depression is documented as negative, a follow-up plan is not required 97 91 $252.00
3016F 1,639 1,539 $231.75
2029F 1,610 1,525 $222.00
3511F 1,431 1,343 $220.50
3015F 1,319 1,174 $209.25
3011F 1,344 1,281 $202.50
4013F 929 851 $195.75
4005F 1,151 1,093 $177.75
99441 19 18 $176.80
3492F 1,018 975 $171.00
0513F 353 317 $162.00
1036F 1,139 1,054 $159.75
92552 15 14 $159.12
G8482 Influenza immunization administered or previously received 1,013 918 $150.00
4010F 851 748 $122.04
3044F 1,667 1,530 $117.53
4004F 795 716 $110.35
4008F 551 494 $108.00
4040F 720 647 $107.57
3079F 1,021 931 $105.98
4086F 689 627 $99.05
3048F 1,008 950 $99.00
3049F 467 433 $92.25
G9902 Patient screened for tobacco use and identified as a tobacco user 34 30 $90.00
99406 25 22 $78.84
G0444 Annual depression screening, 5 to 15 minutes 140 134 $74.91
G8431 Screening for depression is documented as being positive and a follow-up plan is documented 33 31 $67.50
G0245 Initial physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) which must include: (1) the diagnosis of lops, (2) a patient history, (3) a physical examination that consists of at least the following elements: (a) visual inspection of the forefoot, hindfoot and toe web spaces, (b) evaluation of a protective sensation, (c) evaluation of foot structure and biomechanics, (d) evaluation of vascular status and skin integrity, and (e) evaluation and recommendation of footwear and (4) patient education 15 15 $62.87
4140F 480 436 $60.75
4050F 452 415 $51.75
2028F 264 233 $51.75
3075F 421 396 $49.59
2027F 221 195 $45.00
3077F 469 411 $40.69
2022F 275 243 $38.31
3050F 232 218 $38.25
3014F 515 480 $31.50
3080F 517 457 $29.49
1160F 5,163 4,409 $29.32
G8598 Aspirin or another antiplatelet therapy used 24 22 $22.50
G0442 Annual alcohol misuse screening, 5 to 15 minutes 121 111 $16.41
4322F 81 74 $11.25
3061F 17 15 $4.50
G8754 Most recent diastolic blood pressure < 90 mmhg 45 39 $2.25
G8752 Most recent systolic blood pressure < 140 mmhg 43 37 $2.25
3008F 442 405 $0.02
3045F 53 46 $0.01
3017F 787 707 $0.00
2014F 141 137 $0.00
1090F 27 20 $0.00
1159F 37 34 $0.00